Aeterna Zentaris
AEZS
#10198
Rank
โ‚ฌ15.04 M
Marketcap
4,91ย โ‚ฌ
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

Aeterna Zentaris (AEZS) - Total debt

Total debt on the balance sheet as of June 2024 : โ‚ฌ1.44 Million

According to Aeterna Zentaris's latest financial reports the company's total debt is โ‚ฌ1.44 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Aeterna Zentaris - Total debt on balance sheet (from 2024 to 2024)

Total debt by year

Year Total debt Change
2022-12-31โ‚ฌ0.16 M17.38%
2021-12-31โ‚ฌ0.14 M-4.97%
2020-12-31โ‚ฌ0.14 M-81.44%
2019-12-31โ‚ฌ0.8 M
2018-12-31N/A
2011-12-31โ‚ฌ0.05 M
2008-12-31โ‚ฌ0.15 M-70.22%
2007-12-31โ‚ฌ0.53 M-50.78%
2006-12-31โ‚ฌ1.07 M-95.82%
2005-12-31โ‚ฌ25.81 M-44.89%
2004-12-31โ‚ฌ46.84 M96.99%
2003-12-31โ‚ฌ23.78 M-30.32%
2002-12-31โ‚ฌ34.13 M246.51%
2001-12-31โ‚ฌ9.85 M174.59%
2000-12-31โ‚ฌ3.58 M33.89%
1999-12-31โ‚ฌ2.67 M1123.04%
1998-12-31โ‚ฌ0.21 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Spectrum Pharmaceuticals
SPPI
โ‚ฌ24.77 M 1,609.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ27.50 B 1,898,062.42%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Bristol-Myers Squibb
BMY
โ‚ฌ43.83 B 3,025,448.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ21.92 B 1,513,314.34%๐Ÿ‡ซ๐Ÿ‡ท France
Halozyme Therapeutics
HALO
โ‚ฌ1.29 B 89,453.05%๐Ÿ‡บ๐Ÿ‡ธ USA